Trials / Completed
CompletedNCT01385111
Combined Application of EBUS and EUS in Lung Cancer
Combined Application of EBUS-TBNA and EUS-B-FNA in Mediastinal Staging of Lung Cancer; EBUS-TBNA Centered Procedure vs. EUS-B-FNA Centered Procedure, a Randomized Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 162 (actual)
- Sponsor
- National Cancer Center, Korea · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate a diagnostic yield and performance characteristics according to the order of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) and endoscopic ultrasound-with bronchoscope-guided transbronchial needle aspiration (EUS-B-FNA) in the mediastinal staging of potentially operable lung cancer. EUS-FNA is a better tolerated procedure than EBUS-TBNA. Therefore, EUS-B-FNA can be the main procedure in a combined approach with EBUS-TBNA and EUS-B-FNA. In group A, the investigators perform EBUS-TBNA first and EUS-B-FNA is performed when necessary. In group B, EUS-B-FNA is first applied and EBUS-TBNA is performed when necessary. The hypothesis is that the diagnostic yield of the EUS centered procedure is as good as that of the EBUS centered procedure and the EUS centered procedure is more tolerable than the EBUS centered procedure. We evaluate diagnostic yields and performance characteristics of each group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | EUS-B-FNA followed by EBUS-TBNA | EUS-B-FNA will be performed followed by EBUS-TBNA when additional needle aspiration is necessary after EBUS-TBNA. |
| PROCEDURE | EBUS-TBNA followed by EUS-B-FNA | EBUS-TBNA will be performed followed by EUS-B-FNA when additional needle aspiration is necessary after EUS-B-FNA |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2011-06-29
- Last updated
- 2012-10-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01385111. Inclusion in this directory is not an endorsement.